Literature DB >> 9691926

Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features.

L De Moliner1, P Pontisso, G L De Salvo, L Cavalletto, L Chemello, A Alberti.   

Abstract

BACKGROUND: Liver disease in chronic hepatitis C virus (HCV) infection ranges from minimal lesions to liver cirrhosis, eventually evolving to hepatocellular carcinoma. Whether and how HCV determines the different clinical and histological manifestations of the disease is not fully understood. AIMS: To verify whether the amount of virus in individual patients could be related to the severity of liver injury. PATIENTS AND METHODS: Levels of HCV RNA were measured in serum in 96 consecutive patients with chronic hepatitis type C using a signal amplification assay. The relation between viraemic values and the corresponding viral load in the liver was assessed in a subgroup of 21 patients in whom HCV RNA was measured in serum samples and liver specimens obtained at the same time.
RESULTS: A positive correlation was observed between the amount of viral nucleic acid in the two compartments, indicating that levels of viraemia reflect the amount of virus present in the liver. Viral load did not correlate with aminotransferase activities nor with histological diagnosis, and serum and liver levels of HCV RNA were not significantly different in patients infected by the various HCV genotypes.
CONCLUSIONS: Measurement of HCV replication in serum is a mirror of viral replication in the liver. The extent of replicative activity of HCV does not seem to play a role in the modulation of the associated hepatic disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691926      PMCID: PMC1727134          DOI: 10.1136/gut.42.6.856

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

Review 1.  Immunologic and molecular basis of viral persistence. The hepatitis B virus model.

Authors:  V Barnaba; F Balsano
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

Review 2.  Virus-host interaction in chronic hepatitis B virus infection.

Authors:  H C Thomas; M Jacyna; J Waters; J Main
Journal:  Semin Liver Dis       Date:  1988-11       Impact factor: 6.115

3.  Implications of variations of "conserved" regions of hepatitis C virus genome.

Authors:  J Y Lau; P Simmonds; M S Urdea
Journal:  Lancet       Date:  1995-08-12       Impact factor: 79.321

4.  Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C.

Authors:  E Coelho-Little; L J Jeffers; M Bartholomew; K R Reddy; E R Schiff; P J Dailey
Journal:  J Hepatol       Date:  1995-04       Impact factor: 25.083

5.  Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.

Authors:  D R Gretch; C dela Rosa; R L Carithers; R A Willson; B Williams; L Corey
Journal:  Ann Intern Med       Date:  1995-09-01       Impact factor: 25.391

6.  Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification.

Authors:  K Krawczynski; M J Beach; D W Bradley; G Kuo; A M di Bisceglie; M Houghton; G R Reyes; J P Kim; Q L Choo; M J Alter
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

7.  Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection.

Authors:  D Prati; C Capelli; A Zanella; F Mozzi; P Bosoni; M Pappalettera; F Zanuso; L Vianello; E Locatelli; C de Fazio; G Ronchi; E del Ninno; M Colombo; G Sirchia
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

8.  Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group.

Authors:  J Y Lau; G L Davis; L E Prescott; G Maertens; K L Lindsay; K Qian; M Mizokami; P Simmonds
Journal:  Ann Intern Med       Date:  1996-05-15       Impact factor: 25.391

9.  Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 495 patients with chronic hepatitis C.

Authors:  P Pontisso; M G Ruvoletto; M Nicoletti; S Tisminetzky; M Gerotto; M Levrero; M Artini; M Baldi; G Ballardini; L Barbara
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

10.  An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5' noncoding region.

Authors:  C Wang; S Y Le; N Ali; A Siddiqui
Journal:  RNA       Date:  1995-07       Impact factor: 4.942

View more
  19 in total

1.  Response of combination therapy on viral load and disease severity in chronic hepatitis C.

Authors:  Deepak Kumar; Abdul Malik; Mohammad Asim; Anita Chakravarti; Rakha H Das; Premashis Kar
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

2.  Hepatitis C virus heterogeneity: lipoprotein and immunoglobulin binding and clinical status.

Authors:  Nikki Rae Adler; Marian Biddle; Lauren Beswick; Christopher Hair; Benjamin Allen; Stephen Graves; Aminul Islam; Jonathan P Watson
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

3.  Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR.

Authors:  Peter A White; Yong Pan; Anthony J Freeman; George Marinos; Rosemary A Ffrench; Andrew R Lloyd; William D Rawlinson
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time.

Authors:  L Martin Lagging; Clementina E Garcia; Johan Westin; Rune Wejstål; Gunnar Norkrans; Amar P Dhillon; Magnus Lindh
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Histological damage in chronic hepatitis C is not related to the extent of infection in the liver.

Authors:  E Rodríguez-Iñigo; J Bartolomé; S de Lucas; F Manzarbeitia; M Pardo; C Arocena; J Gosálvez; H Oliva; V Carreño
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

6.  The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.

Authors:  David P Durham; Laura A Skrip; Robert Douglas Bruce; Silvia Vilarinho; Elamin H Elbasha; Alison P Galvani; Jeffrey P Townsend
Journal:  Clin Infect Dis       Date:  2015-11-30       Impact factor: 9.079

7.  Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus.

Authors:  J M Matthews-Greer; G C Caldito; S D Adley; R Willis; A C Mire; R M Jamison; K L McRae; J W King; W L Chang
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

8.  Influence of quasispecies on virological responses and disease severity in patients with chronic hepatitis C.

Authors:  Deepak Kumar; Abdul Malik; Mohammad Asim; Anita Chakravarti; Rakha-H Das; Premashis Kar
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  Hepatitis C virus infection in infants and children from Argentina.

Authors:  María Inés Gismondi; Estela Inés Turazza; Saúl Grinstein; María Cristina Galoppo; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

10.  Dynamics of hepatitis C virus replication in human liver.

Authors:  Ming Chang; Ocean Williams; John Mittler; Adrian Quintanilla; Robert L Carithers; James Perkins; Lawrence Corey; David R Gretch
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.